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Abstract
Background: There is a belief among some society that opium has a number of beneficial effects
on cardiovascular disease. The aim of the present investigation as a cross-sectional study was to
assess this hypothesis. Several biochemical factors (Fasting blood sugar, Cholesterol, Triglyceride,
LDL-Cholesterol, HDL-Cholesterol, HbA1C, CRP, Fibrinogen, Factor VII, SGOT, SGPT, Lpa, apo
A and apo B were evaluated in opium-addicted men (case) against non opium-addicted
men(control). Three hundred and sixty opium-addicted men were divided into three groups
according to the route of administration (Orally, Vafour and Sikh-Sang) and each group was divided
into four subgroups according to the duration of addiction (5 months, 1 year, 2 years and 5 years).
Blood morphine concentration was measured by ELISA method.
Results:  The results show that morphine concentration was significantly higher in orally
administration. In all routes, there was a direct correlation between blood morphine concentration
and period of addiction. Regardless to the period and route of administration, the level of HbA1C,
CRP, factor VII, Fibrinogen, apo B, Lpa, SGOT, and SGPT were significantly higher in the case
subjects as compared with controls and HDL-Cholesterol and apo a were significantly lower in the
case subjects.
Conclusion: This study demonstrated the deleterious effects of opium on some traditional and
new cardiovascular disease risk factors. These deleterious effects are related to the period of
addiction and their levels are significantly increased after 2 years of addiction. Route of
administration impresses cardiovascular risk factors and "Sikh-Sang" showed the worst effect.
Introduction
Papaver somniferum L. is one of the oldest cultivated plants
of mankind and the only commercial source for the nar-
cotic analgesics morphine and codeine [1,2]. Morphine is
a major component of the alkaloid-rich latex in opium
poppy [3]. But the plant contains about eighty different
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tetrahydrobenzylisoquinoline-derived alkaloids [1]
which their effect on metabolism and the endocrine sys-
tem could therefore be extensive and possibly different
from pure morphine [3]. There are beliefs about protec-
tive cardiovascular effects of opium in some societies or
even among a few physicians. It is assumed opium can be
used as an alternative treatment for some of cardiovascu-
lar risk factors specially diabetes[3].
The present study was conducted to assess the effect of
opium on several cardiovascular risk factors according to
the duration of addiction and route of administration.
Three routes of administration were chosen, orally and
two form of inhalation (Vafour and Sikh-Sang) that are
common in Iran. Vafour is a special opium-smoking pipe
which is used to inhale the smoke. In other route (Sikh-
Sang) a stiff is heat and the opium is put on the heated-
stiff by a hairpin; then the smoke is inhaled by a pipe.
Materials and methods
Three hundred and sixty opium-addicted men were
divided into three groups according to the route of admin-
istration (Orally, Vafour and Sikh-Sang) and each group
was divided into four subgroups according to the duration
of addiction (5 months, 1 year, 2 years and 5 years). Blood
morphine concentration was measured by ELISA method
using Bio-quant kit (USA). The control subjects including
360 non-opium addicted but current smokers' men. All
the opium addicts were cigarette smoker too. Both case
and control subjects were selected consecutively from
opium addicted-men and smoker men interested to quit
their addiction or smoking and referred to quit addiction
and rehabilitation center from Isfahan province (center of
Iran). None of case and control group had any special dis-
eases or medications and had no past history of diabetes
and/or dyslipidemia. Dyslipidemia was defined as serum
Cholesterol (Ch) >240 mg/dl, high density lipoprotein
cholesterol (HDL-C)<35 mg/dl, low density lipopro-
tein(LDLC)> 135, serum triglyceride(TG)>200 mg/dl [4].
Fasting blood sugar (FBS) >100 were excluded. Subjects
were informed of the aim of the study and interviews were
performed by a trained nurse. Each participant signed an
informed consent and self-reported opium addiction
(including the route of administration and duration of
opium addiction) and smoking status. The committee for
medical ethics of the Isfahan Cardiovascular Research
Center approved the study protocols. This committee is a
member of Office for Human Research Protections, USA.
Glycosylated hemoglobin (HbA1C) was determined by
column chromatography using a commercial kit (Pars
Azmon, Iran). Lipoprotein a (Lpa) and quantitative C
reactive protein (CRP) were measured by turbidimetric
method (Hitachi 902 autoanalyzer). FBS, Ch, HDL-C, TG,
SGPT and SGOT were determined by enzymatic methods
(Hitachi 902 autoanalyzer). LDL-C was estimated using
the Friedewald equation [5]. Plasma fibrinogen levels and
factor VII were measured by thrombin-mediated clotting
method. Apo B and Apo A were quantified by using a
modified commercially available immunoturbidimetric
assay according to the kit instruction (DiaSys, Germany)).
Statistical analysis
Data expressed as mean ± SD were tested by student's t test
or ANOVA and considered significant at p < 0.05. Analy-
ses were performed with the statistical package SPSS (ver-
sion 11.5, SPSS, Inc).
Results
There was no significant difference between opium-
addicted men and control group in terms of age and the
smoked cigarette/day. Also, there was no significant differ-
ences between different opium addicted groups regarding
smoking. The mean of smoked cigarettes/day was respec-
tively 15 ± 2 and 16 ± 3 in opium addicted and control
group. The mean age of smokers group was 38 ± 5 years
and it was 41 ± 3 years for opium addicted group.
A direct correlation was found between morphine concen-
tration and duration of addiction in all the routes (figure
1). But, in all the durations, the higher morphine concen-
tration was for orally route followed by "Vafour" and
"Sikh-Sang" respectively (figure 1). Blood morphine level
was 18 ± 4 ng/ml in smokers non addicted group.
In the opium addicted subjects, HbA1C, CRP, factor VII,
Fibrinogen, Lpa, apo B, SGOT, and SGPT were signifi-
cantly (p < 0.05) higher as compared with control subjects
and HDL-C and apo A was significantly lower in
them(table 1).
When effects of routes of administration were compared
with each other (regardless to the duration of addiction),
it was found that "Sikh-Sang" presented greater effect on
Ch, TG, Lpa, apo B, CRP and fibrinogen (table 2).
Although CRP and Fibrinogen respectively are signifi-
cantly more in Vafour and orally route. Regardless to the
route of administration as shown in table 3, i) FBS
reduced nonsignificantly when the duration of addiction
increased. ii). No significant differences were observed in
Ch, TG and HDL-C when the period of addiction
increased iii) Lpa, apo B, HbA1C, CRP, SGOT, SGPT,
Fibrinogen, Factor VII and LDL augmented significantly
when the period of addiction increased more than 2 years
but apoA decreased significantly.
Discussion
The results show the deleterious effect of opium on some
traditional and new CVD risk factors including HbA1c,
HDL-C, Lpa, apo B, factor VII, fibrinogen, apo A and CRP.Lipids in Health and Disease 2008, 7:42 http://www.lipidworld.com/content/7/1/42
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Lpa which was significantly more in opium addicted is an
independent risk factor for premature atherosclerosis
[6,7]. High levels of CRP and clotting factors that was seen
in the opium addicts in the present study, suggest that use
of opium increase risk for heart attack or stroke. Inflam-
mation is recognized as a major etiologic determinant of
multiple disease states including myocardial infarction,
stroke, diabetes, and metabolic syndrome, and individu-
als with elevated levels of the inflammatory biomarkers
such as CRP are at increased risk of mortality and morbid-
ity from these conditions[8].
The presenting association between Fibrinogen and CHD
beyond 10 years may imply a casual effect and also there
is association between Factor VII and CHD[9]. Studies
have shown that apoB and apo A are strongly predictors of
myocardial infarction and future cardiovascular
events[10] Meanwhile, reduction of HDL-C in opium
addicts was significant. Numerous clinical and epidemio-
logical studies have demonstrated that plasma concentra-
tions of HDL-C and apo A are inversely linked with CVD
[11]. Both HDLC and apoA have antioxidant, anti-throm-
botic, anti-inflammatory properties, which may be related
to their anti-atherogenic function [12-14].
Relation between morphine concentration and duration of addiction in all the routes of administration (Orally, Vafour and  Sikh-Sang) Figure 1
Relation between morphine concentration and duration of addiction in all the routes of administration (Orally, 
Vafour and Sikh-Sang).
Table 1: Comparison of the mean of biochemical factors between addicted men and control group.
Biochemical factors Normal range addict Non addict P value
FBS (mg/dl) 70–115 79 ± 11 84 ± 15 0.46
HbA1C (%) 5–7.5 8.04 ± 0.91 7.12 ± 2.07 0.03
Ch(mg/dl) 200–239 176 ± 25 169 ± 14 0.22
TG (mg/dl) ≤ 220 138 ± 52 152 ± 41 0.43
HDL-C (mg/dl) 29–80 41 ± 5 44 ± 5 0.032
LDL-C (mg/dl) ≤ 130 92 ± 19 110 ± 14 0.42
Lpa (mg/dl) <30 48.7 ± 3.2 25 ± 2.5 0.001
Apo-A (mg/dl) 110–170 117 ± 18 165 ± 32 0.01
Apo-B (mg/dl) 80–155 144 ± 12 124 ± 8.9 0.037
CRP (mg/dl) <10 4.11 ± 0.7 3.54 ± 0.3 0.029
SGOT (IU/L) 5–40 39.2 ± 2.5 18.3 ± 1.8 0.02
SGPT (IU/L) 5–40 34.3 ± 1.8 11.4 ± 0.6 0.017
Fibrinogen (mg/dl) 250–400 330.2 ± 25 263 ± 17 0.042
Factor VII (%activity) 80–130 243.9 ± 29 123 ± 27 0.014
Data represent as mean ± SD (n = 360), p < 0.05 considered as significantLipids in Health and Disease 2008, 7:42 http://www.lipidworld.com/content/7/1/42
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Even though, FBS reduced in the opium addicted subjects
but it was not significant. Furthermore, the reduction of
FBS was concurrent with increase in HbA1C level then it
could be concluded that reduction of FBS was not a valu-
able outcome because HbA1c provides an integrated
measurement of blood glucose during previous 2–3
months, reflecting 120-day life span of erythrocytes [15].
Also other study is revealed that opium might decrease
blood glucose temporarily [16]. These findings are also in
agreement with Karam et al. [3] that HbA1C was higher in
the opium addict non-insulin-dependent diabetes melli-
tus (NIDDM) men compared to non-opium addict
NIDDM male. They have also reported that opium addic-
tion in NIDDM subjects increased serum glucose and
decreased HDL-C; and thus progress to metabolic disor-
ders in NIDDM patients.
As it expected in all the routes, there was a direct correla-
tion between blood morphine concentration and period
of addiction. Repeated use of opiate drugs, such as mor-
phine, leads to the development of tolerance and depend-
ence [17] which it result in excessive drug consumption.
Then it is usual that blood morphine concentration aug-
ments when the duration of addiction increase. Although,
in all the duration the higher morphine concentration was
reported in the route of orally but the worst effect was
observed in "Sikh-Sang". This observation suggests that
destructive effects of opium are related to other com-
pounds in opium or may be the route of administration
influence diverse metabolic pathways by different mecha-
nisms. Even though, the mechanisms of these differences
are not clear but different outcomes have been mentioned
for various routes of opium administration. For example,
it has been reported that the onset of action of opium is
delayed after oral ingestion of opium (contains morphine
and codeine), because opium is poorly absorbed in the
stomach but well absorbed in the small intestine.
Table 2: The mean ± SD of biochemical factors in opium addicted men based on the route of addiction
Biochemical factors Vafour Sikh-sang Orally
FBS (mg/dl) 81.3 ± 15.3 82.2 ± 13.2 74.9 ± 12.6
HbA1C (%) 8.9 ± 0.7 8.5 ± 0.8 8.8 ± 0.8
Ch(mg/dl) 172.3 ± 28.3 180.8* ± 28.6 175.5 ± 29.0
TG (mg/dl) 119.6 ± 69.6 160.9* ± 32.2 136.1 ± 50.6
HDL-C (mg/dl) 40.8 ± 4.9 38.3 ± 3.07 37.9 ± 2.7
LDL-C (mg/dl) 83.7 ± 38.4 107.2 ± 21.2 108.4 ± 22.4
Lpa (mg/dl) 47.0 ± 38.9 56.5* ± 39.1 42.1 ± 35.1
Apo-A (mg/dl) 118.8 ± 21.3 114.8 ± 29.3 119.9 ± 21.80
Apo-B (mg/dl) 124.8 ± 29.9 169.8* ± 31.3 139.6 ± 23.58
CRP (mg/dl) 3.7* ± 1.6 3.4* ± 1.6 2.8 ± 1.6
SGOT (IU/L) 26.9 ± 12.5 28.1 ± 12.1 48 ± 35.1
SGPT (IU/L) 28.1 ± 16.9 41.8 ± 16.3 48 ± 34.5
Fibrinogen (mg/dl) 275 ± 18 345* ± 37 389* ± 12
Factor VII (%activity) 239 ± 12 253 ± 23 257 ± 18
Data represent as mean ± SD, p < 0.05 considered as significant
Table 3: The mean ± SD of biochemical factors in opium addicted men based on the period of addiction
Biochemical factors 5 months 1 year 2 years 5 years
FBS (mg/dl) 80.6 ± 11.9 80.3 ± 15.96 81.9 ± 16.8 74.6 ± 9.0
HbA1C (%) 6.8 ± 0.9 7.2 ± 0.9 9.0* ± 0.72 9.5* ± 0.7
Ch(mg/dl) 174.8 ± 25.7 180.0 ± 29.0 177.5 ± 30.5 170.9 ± 27.4
TG (mg/dl) 124.7 ± 54.9 122.92 ± 67.3 120.8 ± 59.5 147.4 ± 48.1
HDL-C (mg/dl) 38.34 ± 3.2 37.3 ± 2.1 39.9 ± 3.8 38.6 ± 3.3
LDL-C (mg/dl) 87.2 ± 39.92 73.7 ± 45.5 105.1* ± 28.6 103.0* ± 19.2
Lpa (mg/dl) 35.2 ± 37.4 41.1 ± 21.1 50.9* ± 41.2 68.1* ± 37.6
Apo-A (mg/dl) 141.9 ± 15.11 125.8 ± 25.9 99.9* ± 22.9 100.0* ± 25.6
Apo-B (mg/dl) 113.4 ± 47.7 115.6 ± 41.8 152.3* ± 29.8 184.0 ± *23.6
CRP (mg/dl) 2.7 ± 0.2 2.7 ± 0.6 4.5* ± 0.6 5.4* ± 0.6
SGOT (IU/L) 18.5 ± 1.3 23.6 ± 2.4 40.2* ± 4.5 47.4* ± 5.2
SGPT (IU/L) 26.8 ± 2.1 29.3 ± 5.3 42.8* ± 4.8 49.2* ± 5.7
Fibrinogen (mg/dl) 270 ± 12 298 ± 32 408* ± 31 450* ± 12
Factor VII (%activity) 122 ± 14 134 ± 28 316* ± 32 342* ± 81
Data represent as mean ± SD, p < 0.05 considered as significantLipids in Health and Disease 2008, 7:42 http://www.lipidworld.com/content/7/1/42
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In contrast, vaporized morphine produced by smoking of
opium is rapidly absorbed across the lungs into the blood
stream, and within a few seconds is available at the brain.
Hence the onset of action is more rapid after smoking;
however, the duration of action is longer after oral inges-
tion [18]. This is also in agree with several reports that
shown orally administrated addictive substances such as
cannabinoids have a slower onset of action but due to the
rapid delivery to the brain, they are more addictive when
smoked than when administered by other routes [19,20].
By the way, it has been reported that morphine increases
hormones such as adrenalin, noradrenalin, corticoster-
one, prolactin and glucagons which affect the metabolism
in different ways [21]. Short- and long-term effects of
morphine on the hormone secretion are different.
The reduction of TG, Ch, and LDL which was observed in
the opium addicts in the present study were not signifi-
cant. Furthermore, one of the main factors influencing
blood lipids that are not taken into account in this study
is the diet. On the other hand, nutritional habits, social
status and unfavorable lifestyle behaviors could influence
the blood lipid profile in a person. Usually the opium
addicts have malnutrition may be due to economical
problems, they prefer to save their money for buying
opium instead food or loss of appetite due to the effect of
opium. It is worthy to consider that this study indicate the
level of cardiovascular risk factors are significantly more
in opium addicted men than smoker men, while smoking
is one of the important risk factor of cardiovascular dis-
ease and cancer[22-24], therefore the deleterious effects of
opium addiction on cardiovascular disease are considera-
ble.
Route of administration impresses cardiovascular risk fac-
tors and "Sikh-Sang" showed the worst effect. Effect of dif-
ferent temperatures on opium compounds during certain
routes, effect of pipe on filtration of opium smoke in
"Vafour" and effect of digestive enzymes on opium com-
pounds during orally route should be more investigated.
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